Alan Teo, M.D., is interviewed about the condition of extreme social isolation known as hikikomori.

Alan Teo, M.D., is interviewed about the condition of extreme social isolation known as hikikomori.

Fennec Pharmaceuticals announces next phases in the FDA approval of PEDMARK, a unique formulation of sodium thiosulfate that – based on research conducted at OHSU – can help to prevent pediatric ototoxicity caused by cisplatin chemotherapy.

The Order of the Eastern Star group in Coos Bay hosts breakfast fundraiser benefiting breast cancer research efforts at the OHSU Knight Cancer Institute.

OHSU is one of 17 large power consumers who will purchase energy from a 162-megawatt solar power plant being built in Gilliam County through PGE’s Green Future Impact program.

While discussing molecular diagnostics to augment the information obtained from thyroid nodule and cancer biopsies, Maisie Shindo, MD, says: “If molecular testing is going to be used, patients should be counseled regarding the potential benefits and limitations of the testing and about possible uncertainties in the therapeutic and long-term clinical implications of the results.”

Viewpoint by Vinay Prasad, M.D., M.P.H., offers that “we would do better to focus on public-health strategies that are less glamorous” in order to see a steeper decline in deaths from cancer.

OHSU is partnering with Imbio to develop artificial intelligence algorithms for healthcare.

A profile of a Portland family of doctors specializing in providing information about cannabis, includes comment from Michelle Cameron, M.D.

Alan Hunter, M.D., describes in the Annals of Internal Medicine how he a diagnosed a fellow passenger with acute Bell palsy, a sudden, temporary weakness in facial muscles as a result of the air pressure changes experienced during flight.